68Ga-NOTA-FAPI04

N/A

Report date: 2025/11/20 16:02:17

NME

Base Information

Drug Name68Ga-NOTA-FAPI04

Drug Alias Name68Ga-NOTA-FAPI-04

ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionFibroblast activation protein alpha modulators

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesBeijing Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Cancer Hospital

Inactive CompaniesN/A

Active IndicationsLymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A